Intervention Review

Alpha2-adrenergic agonists for the management of opioid withdrawal

  1. Linda Gowing1,*,
  2. Michael Farrell2,
  3. Robert Ali1,
  4. Jason M White1

Editorial Group: Cochrane Drugs and Alcohol Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 26 OCT 2008

DOI: 10.1002/14651858.CD002024.pub3

Database Title

Additional Information

How to Cite

Gowing L, Farrell M, Ali R, White JM. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD002024. DOI: 10.1002/14651858.CD002024.pub3.

Author Information

  1. 1

    University of Adelaide, Discipline of Pharmacology, Adelaide, South Australia, Australia

  2. 2

    National Addiction Centre, Institute of Psychiatry, London, UK

*Linda Gowing, Discipline of Pharmacology, University of Adelaide, Frome Road, Adelaide, South Australia, 5005, Australia. linda.gowing@adelaide.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 JUL 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (794K)Full (865K)

  1. Current Version

    Alpha2-adrenergic agonists for the management of opioid withdrawal

    Linda Gowing, Michael Farrell, Robert Ali and Jason M White

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD002024.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Alpha2 adrenergic agonists for the management of opioid withdrawal

    Linda Gowing, Michael Farrell, Robert Ali and Jason M White

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD002024.pub2

  2. Version 1

    Alpha2 adrenergic agonists for the management of opioid withdrawal

    L Gowing, M Farrell, R Ali and J White

    Article first published online: 19 JUL 2004 | DOI: 10.1002/14651858.CD002024

View Full Article (HTML) Summary (59K)Standard (794K)Full (865K)